Personensuche
Personensuche
Es wurde 1 Person gefunden.
Klinik für Nuklearmedizin am Universitätsklinikum Essen
Anschrift
Hufelandstr. 55
45122 Essen
45122 Essen
Telefon
E-Mail
Funktionen
-
Universitätsprofessor/in, Klinik für Nuklearmedizin
Aktuelle Veranstaltungen
-
WiSe 2025
- begl. Vorlesung: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 1
- Anleitung zu selbständigen wissenschaftlichen Arbeiten in der Nuklearmedizin
- Multimodale Bildgebung (PET/CT, PET/MRT, SPECT/CT)
- Moderne metabolische / funktionelle Schnittbildgebung - Standards in der klinischen Versorgung
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
- Anleitung zu selbständigen wissenschaftlichen Arbeiten in der Nuklearmedizin
- begl. Vorlesung: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 1
- Moderne metabolische / funktionelle Schnittbildgebung - Standards in der klinischen Versorgung
- Multimodale Bildgebung (PET/CT, PET/MRT, SPECT/CT)
-
WiSe 2024
- Anleitung zu selbständigen wissenschaftlichen Arbeiten in der Nuklearmedizin
- begl. Vorlesung: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 1
- Moderne metabolische / funktionelle Schnittbildgebung - Standards in der klinischen Versorgung
- Multimodale Bildgebung (PET/CT, PET/MRT, SPECT/CT)
-
SoSe 2024
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Detection and quantification of small and low-uptake lesions for differentiated thyroid carcinoma using non-time-of-flight iodine-124 PET/MRIIn: Medical Physics, Jg. 52, 2025, Nr. 2, S. 837 – 846DOI (Open Access)
-
Dose distributions of proton therapy plans are robust against lowering the resolution of CTs combined with increasing noiseIn: Medical Physics, Jg. 52, 2025, Nr. 2, S. 1293 – 1304DOI (Open Access)
-
Evaluation of Surgical Margins with Intraoperative PSMA PET/CT and their Prognostic Value in Radical ProstatectomyIn: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 3, S. 352 – 358
-
Quantitative evaluation of ¹²³I-MIBG imaging in patients with myocarditis : Impairment of cardiac neuronal function revisitedIn: Annals of Nuclear Medicine, 2025, in pressDOI (Open Access)
-
Thyroid Hormone Withdrawal Yields Higher ¹³¹I Absorbed Dose to Metastases Than rhTSH Stimulation in Differentiated Thyroid Cancer : Evidence from a Large ¹²⁴I PET/CT Dosimetry CohortIn: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 11, S. 1722 – 1728
-
Tumor Dose–Response Relationship of [¹³¹I]MIBG Therapy in Patients with Neural Crest Tumors by Means of [¹²⁴I]MIBG PETIn: Journal of Nuclear Medicine (JNM), Jg. 66, 2025, Nr. 4, S. 641 – 647
-
Biodistribution and radiation dosimetry of ¹²⁴I-mIBG in adult patients with neural crest tumours and extrapolation to paediatric modelsIn: EJNMMI Physics, Jg. 11, 2024, Nr. 1, 3DOI, Online Volltext (Open Access)
-
PET quantification performance of the oversize-volume-of-interest approach in the context of tumour dosimetry in radionuclide therapy planningIn: Physics in Medicine and Biology, Jg. 69, 2024, Nr. 16, 165007DOI (Open Access)
-
Renal and Multiorgan Safety of ¹⁷⁷Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry SubstudyIn: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 1, S. 71 – 78DOI (Open Access)
-
Safety and Efficacy of Para-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine TumorsIn: Journal of Nuclear Medicine (JNM), Jg. 65, 2024, Nr. 6, S. 931 – 937
-
Efficacy and Safety of¹²⁴I-MIBG Dosimetry-Guided High-Activity¹³¹I-MIBG Therapy of Advanced Pheochromocytoma or NeuroblastomaIn: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 6, S. 885 – 891DOI (Open Access)
-
Lesion Quantification Accuracy of Digital 90Y PET Imaging in the Context of Dosimetry in Systemic FAPI Radionuclide TherapyIn: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 2, S. 329 – 336DOI (Open Access)
-
Production of ¹¹C, ¹³N and ¹⁵O in proton-induced nuclear reactions up to 200 MeVIn: Nuclear Data Sheets, Jg. 187, 2023, S. 579 – 596
-
Quantification performance of silicon photomultiplier-based PET for small ¹⁸F-, ⁶⁸Ga- and ¹²⁴I-avid lesions in the context of radionuclide therapy planningIn: Physica Medica: European Journal of Medical Physics, Jg. 114, 2023, 103149DOI (Open Access)
-
Quantitative ⁹⁹mTc-DPD-SPECT/CT assessment of cardiac amyloidosisIn: Journal of Nuclear Cardiology, Jg. 30, 2023, Nr. 1, S. 101 – 111DOI (Open Access)
-
Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision : A phantom studyIn: The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Jg. 67, 2023, Nr. 1, S. 57 – 68
-
Diagnostic Performance of ¹²⁴I-Metaiodobenzylguanidine PET/CT in Patients with PheochromocytomaIn: Journal of Nuclear Medicine (JNM), Jg. 63, 2022, Nr. 6, S. 869 – 874DOI (Open Access)
-
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI) : A Single-Center Prospective Two-Arm StudyIn: Clinical Cancer Research, Jg. 28, 2022, Nr. 19, S. 4194 – 4202DOI (Open Access)
-
First experiences with dynamic renal [⁶⁸Ga]Ga-DOTA PET/CT : A comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rateIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, Nr. 10, S. 3373 – 3386DOI (Open Access)
-
Implementation of a Spatially-Variant and Tissue-Dependent Positron Range Correction for PET/CT ImagingIn: Frontiers in Physiology, Jg. 13, 2022, 818463DOI (Open Access)
-
Intra-therapeutic dosimetry of [¹⁷⁷Lu]Lu-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer patients and correlation with treatment outcomeIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, Nr. 2, S. 460 – 469DOI (Open Access)
-
Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital systemIn: BMC Cancer, Jg. 22, 2022, Nr. 1, 899DOI, Online Volltext (Open Access)
-
Positron range in combination with point-spread-function correction : an evaluation of different implementations for [124I]-PET imagingIn: EJNMMI Physics, Jg. 9, 2022, Nr. 1, 56DOI (Open Access)
-
[⁶⁸Ga]Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [¹⁷⁷Lu]Lu-PSMA-617 treatmentIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, S. 1101 – 1112DOI (Open Access)
-
Can a ToF-PET photon attenuation reconstruction test stopping-power estimations in proton therapy? : A phantom studyIn: Physics in Medicine and Biology, Jg. 66, 2021, Nr. 21, 215010
-
Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancerIn: EJNMMI Physics, Jg. 8, 2021, Nr. 1, 14DOI, Online Volltext (Open Access)
-
Evaluation of [⁶⁸Ga]Ga-PSMA PET/CT images acquired with a reduced scan time duration in prostate cancer patients using the digital biograph visionIn: EJNMMI Research, Jg. 11, 2021, Nr. 1, S. 21DOI, Online Volltext (Open Access)
-
Evaluation of ¹⁸F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph visionIn: BMC Cancer, Jg. 21, 2021, Nr. 1, 62DOI, Online Volltext (Open Access)
-
Experimental consolidation and absolute measurement of the C-nat(p,x)C-11 nuclear activation cross section at 100MeV for particle therapy physicsIn: The European Physical Journal A: Hadrons and Nuclei (EPJ A), Jg. 57, 2021, Nr. 8DOI (Open Access)
-
Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non-Small Cell Lung Cancer Patients Receiving Definitive ChemoradiotherapyIn: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 12, S. 1684 – 1691DOI, Online Volltext (Open Access)
-
Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124In: Scientific Reports, Jg. 11, 2021, Nr. 1, 17477DOI, Online Volltext (Open Access)
-
An international multi-center investigation on the accuracy of radionuclide calibrators in nuclear medicine theragnosticsIn: EJNMMI Physics, Jg. 7, 2020, Nr. 1, 69DOI (Open Access)
-
Post-radiosynovectomy imaging utilizing Erbium-169 citrateIn: Applied Radiation and Isotopes, Jg. 154, 2019, 108853
-
Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules : analysis of the ESPATUE randomized phase 3 trialIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 46, 2019, Nr. 7, S. 1439 – 1447
-
The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancerIn: The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Jg. 63, 2019, Nr. 3, S. 235 – 252
-
¹²⁴ J/¹³¹ J-Theranostik des Natrium-Jodid-Symporters beim SchilddrüsenkarzinomIn: TumorDiagnostik & Therapie, Jg. 40, 2019, Nr. 8, S. 531 – 536
-
Impact of prompt gamma coincidence correction on absorbed dose estimation in differentiated thyroid cancer using 124 i PET/CT imagingIn: Nuclear Medicine Communications, Jg. 39, 2018, Nr. 12, S. 1156 – 1164
-
Pretherapeutic 124 i dosimetry reliably predicts intratherapeutic blood kinetics of 131 i in patients with differentiated thyroid carcinoma receiving high therapeutic activitiesIn: Nuclear Medicine Communications, Jg. 39, 2018, Nr. 5, S. 457 – 464
-
Quantitative performance evaluation of I PET/MRI lesion dosimetry in differentiated thyroid cancerIn: Physics in Medicine and Biology, Jg. 63, 2018, Nr. 1, S. 015014DOI, Online Volltext (Open Access)
-
Quantitative performance of ¹²⁴I PET/MR of neck lesions in thyroid cancer patients using ¹²⁴I PET/CT as referenceIn: EJNMMI Physics, Jg. 5, 2018, Nr. 1, 13DOI, Online Volltext (Open Access)
-
Discrepant salivary gland response after radioiodine and MIBG therapiesIn: The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Jg. 61, 2017, Nr. 3, S. 331 – 339
-
Fixed 3.7-GBq (131)I Activity for Metastatic Thyroid Cancer Therapy Ignores Science and HistoryIn: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. 9, S. 1530DOI (Open Access)
-
Iodine symporter targeting with 124I/131I theranosticsIn: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. Suppl. 2, S. 34S – 38S
-
124I PET Assessment of Response of Bone Metastases to Initial Radioiodine Treatment of Differentiated Thyroid CancerIn: Journal of Nuclear Medicine (JNM), Jg. 57, 2016, Nr. 10, S. 1499 – 1504DOI (Open Access)
-
Dose-Response Relationship in Differentiated Thyroid Cancer Patients Undergoing Radioiodine Treatment Assessed by Means of 124I PET/CTIn: Journal of Nuclear Medicine (JNM), Jg. 57, 2016, Nr. 7, S. 1027 – 1032DOI (Open Access)
-
High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer MetastasesIn: Journal of Nuclear Medicine (JNM), Jg. 57, 2016, Nr. 9, S. 1339 – 1342DOI (Open Access)
-
Metalloporphines : Dimers and TrimersIn: Inorganic Chemistry, Jg. 55, 2016, Nr. 12, S. 6294 – 6299DOI, Online Volltext (Open Access)
-
Optimization of Acquisition time of 68Ga-PSMA-Ligand PET/MRI in Patients with Local and Metastatic Prostate CancerIn: PLoS ONE, Jg. 11, 2016, Nr. 10, S. e0164392DOI (Open Access)
-
Serum Thyroglobulin Doubling Time in Progressive Thyroid CancerIn: Thyroid, Jg. 26, 2016, Nr. 12, S. 1712 – 1718
-
An improved iterative thresholding method to delineate PET volumes using the delineation-averaged signal instead of the enclosed maximum signalIn: Journal of Nuclear Medicine Technology, Jg. 43, 2015, Nr. 1, S. 28 – 35
-
Assessment of simplified blood dose protocols for the estimation of the maximum tolerable activity in thyroid cancer patients undergoing radioiodine therapy using 124IIn: Journal of Nuclear Medicine (JNM), Jg. 56, 2015, Nr. 6, S. 832 – 838DOI (Open Access)
-
Lowest effective 131I activity for thyroid remnant ablation of differentiated thyroid cancer patients : Dosimetry-based model for estimationIn: Nuklearmedizin = Nuclear Medicine, Jg. 54, 2015, Nr. 3, S. 137 – 143
-
Assessment of Lesion Response in the Initial Radioiodine Treatment of Differentiated Thyroid Cancer Using 124I PET ImagingIn: Journal of Nuclear Medicine (JNM), Jg. 55, 2014, Nr. 11, S. 1759 – 1765DOI (Open Access)
-
Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy 124I PET/CT imagingIn: EJNMMI Physics, Jg. 1, 2014, Nr. 1, 100DOI (Open Access)
-
Monte Carlo-based 3-dimensional dosimetry of salivary glands in radioiodine treatment of differentiated thyroid cancer estimated using 124I PETIn: The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Jg. 57, 2013, Nr. 1, S. 79 – 91
-
124I-PET/CT images of differentiated thyroid cancer patients : Distinguishing lymph node metastases from thyroid remnants using kinetic quantitiesIn: Nuklearmedizin = Nuclear Medicine, Jg. 51, 2012, Nr. 6, S. 213 – 216
-
Effects of rosiglitazone on radioiodine negative and progressive differentiated thyroid carcinoma as assessed by 124I PET/CT imagingIn: Clinical Nuclear Medicine, Jg. 37, 2012, Nr. 3
-
Estimation of tumour mass in patients with differentiated thyroid carcinoma using serum thyroglobulinIn: Nuklearmedizin = Nuclear Medicine, Jg. 51, 2012, Nr. 6, S. 217 – 222
-
Malignant pheochromocytoma imaging with [¹²⁴I]mIBG PET/MRIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 97, 2012, Nr. 11, S. 3833 – 3834
-
Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine : Predicted blood doses correlate with changes in blood cell counts after radioiodine therapy and depend on modes of TSH stimulation and number of preceding radioiodine therapiesIn: Annals of Nuclear Medicine, Jg. 26, 2012, Nr. 9, S. 723 – 729
-
Clinical applications of ¹²⁴I-PET/CT in patients with differentiated thyroid cancerIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 38, 2011, Nr. Suppl. 1, S. S48 -S 56
-
Diagnosis and dosimetry in differentiated thyroid carcinoma using ¹²⁴I PET : Comparison of PET/MRI vs PET/CT of the neckIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 38, 2011, Nr. 10, S. 1862 – 1868
-
Neural substrates of good and poor recovery after hemiplegic stroke : A serial pet studyIn: Journal of Neurology, Jg. 258, 2011, Nr. 12, S. 2168 – 2175
-
Quantitative imaging of ¹²⁴I with PET/CT in pretherapy lesion dosimetry : Effects impairing image quantification and their correctionsIn: The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Jg. 55, 2011, Nr. 1, S. 21 – 43
-
Time course of tumor SUV in¹⁸F-FDG PET of breast cancer: Presentation of a simple model using a single reference point for time corrections of tumor SUVsIn: Journal of Nuclear Medicine (JNM), Jg. 52, 2011, Nr. 1, S. 18 – 23
-
⁶⁸Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: Correlation of sst2 mRNA and SUV mₐₓIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 38, 2011, Nr. 7, S. 1224 – 1236
-
Burn injury by nuclear magnetic resonance imagingIn: Clinical Imaging, Jg. 34, 2010, Nr. 4, S. 293 – 297
-
Calcification-related absorption in thyroid scintigraphyIn: Nuklearmedizin = Nuclear Medicine, Jg. 49, 2010, Nr. 1, S. 13 – 18
-
Experimental investigation of factors affecting the absolute recovery coefficients in iodine-124 PET lesion imagingIn: Physics in Medicine and Biology, Jg. 55, 2010, Nr. 8, S. 2365 – 2398
-
Lesion dose in differentiated thyroid carcinoma metastases after rhTSH or thyroid hormone withdrawal : 124I PET/CT dosimetric comparisonsIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 37, 2010, Nr. 12, S. 2267 – 2276
-
Pre-therapeutic 124I PET(/CT) dosimetry confirms low average absorbed doses per administered 131I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancerIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 37, 2010, Nr. 5, S. 884 – 895DOI, Online Volltext (Open Access)
-
The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using ¹²⁴I PET(/CT) imagingIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 37, 2010, Nr. 12, S. 2298 – 2306
-
Thyroid remnant dose: ¹²⁴I-PET/CT dosimetric comparison of rhTSH versus thyroid hormone withholding before radioiodine remnant ablation in differentiated thyroid cancerIn: Experimental and Clinical Endocrinology & Diabetes, Jg. 118, 2010, Nr. 7, S. 393 – 399
-
124I-PET dosimetry in advanced differentiated thyroid cancer : therapeutic impactIn: Nuklearmedizin = Nuclear Medicine, Jg. 46, 2007, Nr. 4, S. 121 – 128
-
Economic Image Compression of Output Documentation of the Most Frequent Examinations in Nuclear MedicineIn: Academic Radiology, Jg. 14, 2007, Nr. 8, S. 967 – 973
-
Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomyIn: European Journal of Endocrinology (EJE), Jg. 153, 2005, Nr. 1, S. 49 – 55
-
Kombinierte PET/CT mit dem Positronenstrahler 124-I bei metastasiertem follikuären SchilddrüsenkarzinomIn: Nuklearmedizin = Nuclear Medicine, Jg. 41, 2002, Nr. 5, S. N68 – 71
-
Occurence of hematotoxic side effects during 90Y-FAPI-46 radioligand therapy (RLT) in patients with advanced metastatic tumor diseases
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S671DOI (Open Access) -
PET Quantification Performance of the Oversize-Volume-of-Interest Approach in the Context of Tumour Dosimetry in Radionuclide Therapy Planning
Annual Congress of the European Association of Nuclear Medicine, 19-13 September 2023, Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S363 -
Performance Evaluation of 18F-PSMA and 68Ga-PSMA in a Novel MicroPET/CT System Dedicated to Radioguided Surgery
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023, Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 50, 2023, Nr. 1 supplement, S. S131 -
Dosimetry of 177Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer : Results from the VISION trial sub-studyIn: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 40, 2022, Nr. Suppl. 6, 97DOI (Open Access)
-
Multi-cycle dosimetry of [Lu-177]Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer : results from the VISION trial sub-study
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S129DOI (Open Access) -
Radiation Exposure of I-124-MIBG Imaging in Adult Patients with Neuroendocrine Tumours
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S36 – S37DOI (Open Access) -
Dicentric trial with iodine-124 PET dosimetry to optimize therapy of metastatic thyroid cancer : PET scanner's SUV verification used to check accuracy of activimetersIn: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. 227
-
Dynamic Ga-68-DOTA PET/CT and Compartmental Modelling to Non-invasively Estimate the Glomerular Filtration RateIn: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 62, 2021, Nr. Suppl. 1, 88
-
Efficacy and safety of 124-I-MIBG guided high activity 131-I-MIBG therapy of metastatic pheochromocytoma and neuroblastomaIn: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. 290 – S291
-
Evaluation of Dynamic Renal Ga-68-DOTA PET/CT to Monitor the Urinary Efflux and to Estimate the Glomerular Filtration Rate Using a Compartmental Kinetic Modelling ApproachIn: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. 340
-
Ga-68-PSMA-11 PET Imaging as a Predictor for Absorbed Doses in Organs at Risk and Small Lesions in Lu-177-PSMA-617 TreatmentIn: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. 76
-
Imaging Properties and Quantification Accuracy of Ga-68 and I-124 in a New Generation Preclinical PET/CT System : A Phantom StudyIn: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 48, 2021, Nr. Suppl. 1, S. 227 – S228
-
An International Multi-Center Investigation on the Accuracy of Radionuclide Calibrators for Theranostics in Nuclear Medicine
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S315DOI (Open Access) -
Comparison of Lesion Detectability and Image Quality among Digital and Analog PET Systems for Recurrence in Thyroid Cancer Patients Using I-124
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S429DOI (Open Access) -
Digital high sensitivity I-124 PET/CT improves the detectability of thyroid cancer metastases
Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, July, 11-14, 2020, Virtual,In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 61, 2020, Nr. Suppl. 1, 255Online Volltext (Open Access) -
Evaluation of 68Ga-PSMA PET/CT Images Acquired with a Reduced Scan Time Duration in Prostate Cancer Patients using a Digital PET/CT Scanner
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S27DOI (Open Access) -
Prognostic Value of Metabolic Tumor Volume after Induction Chemotherapy in Stage IIIA/B Non-Small-Cell Lung Cancer : Secondary Analysis of a Randomized Phase 3 Trial
61st Annual Meeting of the American Society for Radiation Oncology ; September 15-18, 2019, Chicago, IL, USA,In: International Journal of Radiation Oncology, Biology, Physics. New York: Elsevier, Jg. 105, 2019, Nr. 1, Supplement, S. S146 – S147DOI (Open Access) -
BRAF Mutation Analysis for Initial Risk Stratification in High Risk Papillary Thyroid CarcinomaIn: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 45, 2018, Nr. Suppl. 1, S. 551
-
Comparison evaluation of the diagnostic potential of PET/MRI and PET/CT using mIBG-Iod-124 in neuroendocrine and neuroectodermal tumors
Annual Congress of the European Association of Nuclear Medicine, EANM‘18, October 13 – 17, 2018, Düsseldorf, Germany,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 45, 2018, Nr. Suppl. 1, S. S65 -
Small scale dosimetry and modeling for salivary gland toxicity in thyroid cancer patients treated with 131IIn: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 59, 2018, Nr. Suppl. 1, S. 470
-
Estimation of Electron Density from joint Reconstructions of Activity and Attenuation of ToF-PET Scans for Particle TherapyIn: 2022 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) / IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC), 5-12 Nov. 2022, Italy. Piscataway: Institute of Electrical and Electronics Engineers Inc., 2022
-
PET imaging in thyroid cancerIn: Nuclear Medicine and Molecular Imaging: Volume 3: PET studies / Signore, Alberto; Macapinlac, Homer; Treglia, Giorgio (Hrsg.). Amsterdam: Elsevier, 2022, S. 99 – 104
-
Titanium Implants for Field Verification in Proton Therapy - an Applicability TestIn: 2022 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) / IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC), 5-12 Nov. 2022, Italy. Piscataway: Institute of Electrical and Electronics Engineers Inc., 2022
-
Imaging of Differentiated Thyroid Cancer with Iodine-124 and F-18-FDGIn: The Thyroid and Its Diseases: A Comprehensive Guide for the Clinician / Luster, Markus; Duntas, Leonidas H.; Wartofsky, Leonard (Hrsg.). Cham: Springer Science+Business Media, 2019, S. 199 – 204
-
SPECT and PET imaging of the thyroid: Protocols, dosimetry, normal findings, artifacts, and pitfallsIn: Molecular anatomic imaging: PET-CT, PET-MR, and SPECT-CT / von Schulthess, Gustav K. (Hrsg.). Philadelphia [u.a.]: Wolters Kluwer Health Adis (ESP), 2016, S. 223 – 232
-
Etablierung und Evaluierung neuer Konzepte zur Optimierung der RadiojodtherapieDuisburg Essen, 2008
-
Etablierung und Evaluierung neuer Konzepte zur Orientierung der RadiojodtherapieDuisburg, Essen, 2008
-
Prätherapeutische 124I-PET(/CT)-Speicheldrüsendosimetrie bei der Radiojodtherapie differenzierter Schilddrüsenkarzinome und Untersuchung von wichtigen Einflussfaktoren auf die 124I-QuantifizierungDuisburg, Essen, 2010
-
Comparison of the Safety and Tolerability of Paraaminohippurate (PAH) and Amino Acid (AA) Co-Infusion in Patients with Neuroendocrine Tumours Receiving Peptide Receptor Radionuclide Therapy (PRRT) : A Case Series of Eight Patients
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S579DOI (Open Access) -
Lesion Quantification Accuracy of Digital 90Y PET Imaging in the Context of Dosimetry in Systemic FAPI Radionuclide Therapy
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S636DOI (Open Access) -
Positron range correction in combination with resolution recovery image reconstruction of [124I]-PET data
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S610DOI (Open Access) -
Emission time optimisation for [68Ga]Ga-PSMA-11 with a SiPM PET/CT based on phantom measurements
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S256DOI (Open Access) -
Emission time reduction for 2-[18F]FDG examinations in lymphoma patients with a PET/CT with SiPM - a feasibility phantom study
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S257 – S258DOI (Open Access)